AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway

Chenfei Huang, Steven J. Verhulst, Yi Shen, Yiwen Bu, Yu Cao, Yingchun He, Yuhong Wang, Dan Huang, Chun Cai, Krishna Rao,

Oncotarget · 2016 · 38 citations · 32 references

DOIFull text

Open access

Concepts

Abstract

// Chenfei Huang 1 , Steven Verhulst 1 , Yi Shen 1 , Yiwen Bu 1 , Yu Cao 1 , Yingchun He 1, 2 , Yuhong Wang 2 , Dan Huang 2 , Chun Cai 2 , Krishna Rao 1 , Duan-Fang Liao 2 , Junfei Jin 3 , Deliang Cao 1, 2 1 Department of Medical Microbiology, Immunology & Cell Biology, Simmons Cancer Institute, Southern Illinois University School of Medicine, Springfield, IL 62794, USA 2 Division of Stem Cell Regulation and Application, State Key Laboratory of Chinese Medicine Powder and Medicine Innovation in Hunan (incubation), Hunan University of Chinese Medicine, Changsha, Hunan 410208, China 3 China-USA Lipids in Health and Disease Research Center, Guilin Medical University, Guilin, 541001, Guangxi, China Correspondence to: Deliang Cao, email: dcao@siumed.edu Junfei Jin, email: changliangzijin@163.com Keywords: AKR1B10, breast cancer metastasis, integrin α5, δ-catenin, Rac1 Received: March 18, 2016     Accepted: April 29, 2016     Published: May 27, 2016 ABSTRACT Aldo-keto reductase 1B10 (AKR1B10) is not expressed in normal breast, but upregulated in primary and metastatic breast cancers, being a negative prognostic factor. This study characterized the molecular mechanisms of AKR1B10-promoted breast cancer metastasis. Ectopic expression of AKR1B10 in breast cancer cells MCF-7 and MDA-MB-231 or siRNA-mediated silencing in BT-20 cells affected cell adhesion, migration and invasion in cell culture, and metastasis to the lung in the nude mice through upregulation of integrin α5 and δ-catenin. Silencing of integrin α5 or δ-catenin eradicated the cell adhesion and migration enhanced by AKR1B10, both of which acted synergistically. In these cells, the integrin α5 mediated focal adhesion kinase (FAK) signaling pathway was activated by AKR1B10, which, along with δ-catenin, stimulated Rac1-mediated cell migration and movement. In human primary and lymph node metastatic breast cancer, AKR1B10, integrin α5 and δ-catenin were correlatively upregulated with r=0.645 (p<0.0001) and r=0.796 (p<0.0001), respectively. These data suggest that AKR1B10 promotes breast cancer metastasis through activation of the integrin α5 and δ-catenin mediated FAK/Src/Rac1 signaling pathway.

References

32